Patents Assigned to Board of Regents, The University of Texas System and Peregrine Pharmaceuticals, Inc.
  • Combined methods for tumor vasculature coagulation and treatment
    Publication number: 20030139374
    Abstract: Disclosed are various defined combinations of agents for use in improved anti-vascular therapies and coagulative tumor treatment. Particularly provided are combined treatment methods, and associated compositions, pharmaceuticals, medicaments, kits and uses, which together function surprisingly effectively in the treatment of vascularized tumors. The invention preferably involves a component or treatment step that enhances the effectiveness of therapy using targeted or non-targeted coagulants to cause tumor vasculature thrombosis.
    Type: Application
    Filed: September 27, 2002
    Publication date: July 24, 2003
    Applicant: Board of Regents, The University of Texas System and Peregrine Pharmaceuticals, Inc.
    Inventors: Philip E. Thorpe, Steven W. King, Claudia Gottstein
  • Combined methods for tumor vasculature coaguligand treatment
    Publication number: 20030129193
    Abstract: Disclosed are various defined combinations of agents for use in improved anti-vascular therapies and coagulative tumor treatment. Particularly provided are combined treatment methods, and associated compositions, pharmaceuticals, medicaments, kits and uses, which together function surprisingly effectively in the treatment of vascularized tumors. The invention preferably involves a component or treatment step that enhances the effectiveness of therapy using targeted or non-targeted coagulants to cause tumor vasculature thrombosis.
    Type: Application
    Filed: September 27, 2002
    Publication date: July 10, 2003
    Applicant: Board of Regents, The University of Texas System and Peregrine Pharmaceuticals, Inc.
    Inventors: Philip E. Thorpe, Steven W. King, Claudia Gottstein